Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even existing guidelines contain inconsistencies. We aimed to develop a treatment algorithm for iOAB for use in daily clinical practice. From October 2018 till November 2019, a Delphi study was conducted to obtain expert consensus on the management of iOAB. Members from the Belgian Working Group of Functional Urology were asked to rate online statements, based on gaps and variabilities between the American Urology Association (AUA), European Association of Urology (EAU) and International Consultation on Incontinence (ICI) guidelines on iOAB. The consensus was reach...
BACKGROUND: For women with overactive bladder (OAB), current guidelines recommend the use of urodyna...
Purpose: We developed a consensus on best practice in the real-life management of patients with over...
Overactive bladder syndrome is highly prevalent, and increasingly so with aging. It is characterized...
AIMS: Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice....
Aims Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. ...
PURPOSE: We aimed to explore the pathways followed by patients with overactive bladder (OAB) from re...
AimsTo review and assess the definitions of drug resistance and the evidence supporting treatment fo...
Overactive bladder (OAB) affects an estimated 49 million people in Europe, but only a minority recei...
PubMedID: 31338880Introduction: Turkish Continence Society aimed to analyze how overactive bladder (...
Aims: Botulinum toxin A (BTX-A), sacral nerve stimulation (SNM), and posterior tibial nerve stimulat...
International audienceCONTEXT:A considerable number of patients affected by the overactive bladder s...
INTRODUCTION: Turkish Continence Society aimed to analyze how overactive bladder (OAB) is being mana...
Overactive bladder (OAB) is a heterogeneous syndrome estimated to affect approximately 10% to 15% of...
PURPOSE: We aimed to explore the pathways followed by patients with overactive bladder (OAB) from re...
BACKGROUND: For women with overactive bladder (OAB), current guidelines recommend the use of urodyna...
Purpose: We developed a consensus on best practice in the real-life management of patients with over...
Overactive bladder syndrome is highly prevalent, and increasingly so with aging. It is characterized...
AIMS: Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice....
Aims Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. ...
PURPOSE: We aimed to explore the pathways followed by patients with overactive bladder (OAB) from re...
AimsTo review and assess the definitions of drug resistance and the evidence supporting treatment fo...
Overactive bladder (OAB) affects an estimated 49 million people in Europe, but only a minority recei...
PubMedID: 31338880Introduction: Turkish Continence Society aimed to analyze how overactive bladder (...
Aims: Botulinum toxin A (BTX-A), sacral nerve stimulation (SNM), and posterior tibial nerve stimulat...
International audienceCONTEXT:A considerable number of patients affected by the overactive bladder s...
INTRODUCTION: Turkish Continence Society aimed to analyze how overactive bladder (OAB) is being mana...
Overactive bladder (OAB) is a heterogeneous syndrome estimated to affect approximately 10% to 15% of...
PURPOSE: We aimed to explore the pathways followed by patients with overactive bladder (OAB) from re...
BACKGROUND: For women with overactive bladder (OAB), current guidelines recommend the use of urodyna...
Purpose: We developed a consensus on best practice in the real-life management of patients with over...
Overactive bladder syndrome is highly prevalent, and increasingly so with aging. It is characterized...